NASAL MYIASIS

(10 Marks - ENT Postgraduate Level)

1. DEFINITION

• Harrison's Principles of Internal Medicine, 22e (McGraw-Hill, 2025): "Larvae that infest decaying tissues may enter body cavities such as the mouth, nose, ears, sinuses, anus, vagina, and lower urinary tract, particularly in unconscious or otherwise debilitated patients. The consequences range from harmless colonization to destruction of the nose, meningitis, and deafness."

2. ETIOLOGY AND CAUSATIVE ORGANISMS

A. Specific (Obligatory) Myiasis

• Dermatobia hominis (Human botfly) - neotropical regions of Central/South America
• Oestrus ovis (Sheep nasal botfly) - particularly causes nasal/nasopharyngeal myiasis in sheep-rearing communities; larvae deposited directly in the nostril by the adult fly

B. Semi-specific (Facultative) Myiasis

• Chrysomya bezziana (Old World screwworm) - Africa, Asia, Australia; most common cause of nasal myiasis in India and Asia
• Cochliomyia hominivorax (New World screwworm) - Americas
• Wohlfahrtia magnifica (Flesh fly) - Europe and Asia
• Lucilia sericata, Lucilia cuprina (Greenbottle/blowflies)
• Calliphora spp. (Bluebottle flies)
• Megaselia spiracularis (Phorid fly) - rare, nosocomial cases reported (Shimizu et al., Intern Med, 2026 [PMID: 40803864])

C. Accidental Myiasis

3. EPIDEMIOLOGY

• Global distribution - higher prevalence in tropics and subtropics of Asia, Africa, and the Americas
• Seasonal variation: year-round in tropics; restricted to summer in temperate zones
• In India, Chrysomya bezziana accounts for the majority of cases
• Nasal myiasis was the most common subtype of ORL myiasis (33/67 cases) in a large case series of otorhinolaryngological myiasis (Rana et al., Ghana Med J, 2020 [PMID: 33883762])
• Increasing incidence in Western countries due to international travel

4. PREDISPOSING FACTORS / RISK FACTORS

• Warm, moist, blood-soaked, or malodorous nasal tissue attracts gravid flies
• Atrophic rhinitis is the single most important predisposing condition in India, as the wide, odorous nasal cavity with crusted, necrotic tissue provides an ideal environment
• Dermatology 2-Volume Set 5e (Elsevier): "In wound myiasis, an open wound or orifice attracts flies to deposit their eggs. Any body area can be infested, and the most serious sequelae occur when the nasal cavity, sinuses, or scalp are involved."

5. PATHOGENESIS

1. Gravid female fly is attracted to foul-smelling, suppurating, or necrotic nasal tissue
2. Eggs are deposited at the nares, nasal vestibule, or within the nasal cavity; some species deposit larvae directly (larviposition)
3. Eggs hatch within 12-24 hours under warm, moist conditions
4. First-instar larvae (1 mm) penetrate mucosa and migrate deeper
5. Larvae pass through three instars (L1 → L2 → L3) over days to weeks, feeding on tissue
6. Larvae produce proteolytic enzymes and mechanical trauma, causing progressive tissue destruction
7. Secretions attract more flies, amplifying infestation ("aggregation phenomenon")
8. If untreated, larvae may penetrate through the cribriform plate into the anterior cranial fossa, or into the orbits via the ethmoid sinuses
9. Third-instar larvae (L3) mature and exit the host to pupate on the ground

6. CLINICAL FEATURES

Symptoms

Signs

• Visible maggots or larvae on anterior rhinoscopy - may be white, cream-colored, or brownish
• Mucosal congestion, edema, ulceration, and necrotic sloughing
• Destruction of nasal septum, inferior turbinates, and lateral nasal wall in advanced cases
• Involvement of maxillary, ethmoid, and frontal sinuses in severe cases
• Preseptal or orbital cellulitis (rare but documented)
• Meningitis, cavernous sinus thrombosis (with intracranial extension - rare)

Staging (Sharma et al., J Laryngol Otol, 1989; classical reference)

• Stage I: Confined to nasal vestibule and anterior nasal cavity
• Stage II: Posterior nasal cavity, nasopharynx, paranasal sinuses
• Stage III: Orbital involvement (via ethmoids)
• Stage IV: Intracranial extension (life-threatening)

7. DIAGNOSIS

Clinical Diagnosis

• History of exposure + predisposing factors + characteristic symptoms
• Anterior rhinoscopy: Direct visualization of larvae - sufficient for diagnosis in most cases
• Nasal endoscopy (rigid/flexible): Gold standard; delineates extent of infestation, identifies larvae in posterior nasal cavity, nasopharynx, and sinus ostia; allows simultaneous removal

Investigations

• CT scan of paranasal sinuses: Mandatory in advanced cases to assess sinus involvement, bony destruction, orbital extension, or intracranial spread
• MRI: Superior for soft tissue delineation and intracranial extension
• Larval identification: Removed larvae are examined macroscopically (size, morphology, spiracles) and microscopically (histological cross-section shows chitinous spines); culture of pupae allows species identification
• Wound swab culture: For secondary bacterial infection
• Routine bloods: CBC (eosinophilia may be present), blood glucose (screen for diabetes)

8. DIFFERENTIAL DIAGNOSIS

• Atrophic rhinitis (ozaena)
• Foreign body nose
• Rhinosporidiosis
• Inverted papilloma
• Nasal malignancy (especially in chronic destructive cases)
• Granulomatosis with polyangiitis (Wegener's)
• Rhinoscleroma
• Leishmaniasis

9. TREATMENT

A. Mechanical/Physical Removal (Primary Treatment)

1. Nasal endoscopic removal: Under topical/local anesthesia with rigid endoscopy (0° and 30° Hopkins rod). Larvae are removed with Blakesley forceps or suction. This is the mainstay of treatment - multiple sessions may be required.
2. Nasal irrigation (douching): Saline or chloroform-water (1% chloroform in saline) irrigation to flush out larvae and debris; performed via syringe or irrigation cannula
3. Turpentine oil packing: Nasal packs soaked in turpentine oil suffocate larvae; this is a traditional method still used in resource-limited settings
4. Chloroform in liquid paraffin: Applied topically; paralyzes/kills larvae, facilitating removal

B. Pharmacological Treatment

• Mechanism: Glutamate-gated chloride channel agonist; causes irreversible paralysis of larvae
• Dose: 200 mcg/kg single oral dose (standard); some protocols use repeat dose at 1-2 weeks
• Ivermectin irrigation: Direct nasal irrigation with ivermectin solution (1% ivermectin in propylene glycol diluted in saline) is effective (Tay et al., BMJ Case Rep, 2018)
• Combination oral + nasal irrigation used in refractory cases (Camron et al., Otolaryngol Case Rep, 2023)
• Advantage: Reaches larvae in inaccessible sinuses and posterior cavity

• Chloroform-in-oil (1:9): Kills larvae on contact
• Turpentine oil: Traditional larvicidal
• Saline irrigation: Adjunct for washing out killed/stunned larvae

• Systemic broad-spectrum antibiotics (amoxicillin-clavulanate, cephalosporins) for secondary bacterial infection, which is almost universally present
• Anaerobic cover (metronidazole) for foul-smelling wounds

• Tetanus toxoid/immunoglobulin - Dermatology 2-Volume Set 5e: "Myiasis can be a portal of entry for Clostridium tetani, and vaccination of affected individuals should be considered."

C. Surgical Treatment

• Functional endoscopic sinus surgery (FESS): For larvae involving the paranasal sinuses
• Debridement of necrotic tissue
• Orbital decompression (in cases with orbital extension)
• Neurosurgical consultation for intracranial extension

D. Wound Care

• Daily dressing of the nasal cavity with antiseptic-soaked ribbon gauze
• Treatment of underlying predisposing condition (control of diabetes, atrophic rhinitis management, etc.)

10. COMPLICATIONS

11. PREVENTION

• Adequate treatment of underlying nasal pathology (especially atrophic rhinitis)
• Personal and household hygiene
• Fly control measures (screens, insecticides, proper waste disposal)
• Regular wound care in bedridden/ICU patients, particularly those with nasogastric tubes
• Nursing care protocols to prevent fly access to vulnerable patients
• Awareness among healthcare workers in tropical regions (Rana et al., Ghana Med J, 2020)
• In endemic areas, clothing should be ironed after sun-drying (Dermatology 2-Volume Set 5e)

12. RECENT ADVANCES / SPECIAL CONSIDERATIONS

• Nosocomial nasal myiasis is a recognized complication in ICU settings; Megaselia spiracularis has caused nasal myiasis in hospitalized patients (Shimizu et al., Intern Med, 2026 [PMID: 40803864])
• Nasal myiasis mimicking allergic rhinitis has been described in immunocompetent adults - 14 cases showing rhinitis-like presentation (MDPI Tropical Medicine, 2025)
• A 2025 PMC case report documents nasal myiasis presenting with epistaxis as the presenting feature in an immunocompetent young individual (ENT, Mahatma Gandhi Medical College, PMC11890685)
• Combination ivermectin therapy (oral + topical nasal irrigation) shows superior larval clearance in recent case series (Camron et al., Otolaryngol Case Rep, 2023)
• Kuo et al. (J Central South Univ Med, 2021 [PMID: 35232917]) highlight that altered-consciousness patients (coma, stroke) are a particularly high-risk group requiring preventive nasal care protocols

SUMMARY TABLE

REFERENCES

1. Harrison's Principles of Internal Medicine, 22e (McGraw-Hill, 2025) - Chapter 472: Ectoparasite Infestations
2. Dermatology 2-Volume Set, 5e (Elsevier/Griffiths et al.) - Chapter 84: Cutaneous Myiasis
3. Medical Microbiology 9e (Murray et al., Elsevier, 2021) - Chapter 77: Myiasis-Causing Flies
4. Bosmia AN et al. "Nasal Myiasis in Hinduism and Contemporary Otorhinolaryngology." J Relig Health 2017. [PMID: 24385004]
5. Rana AK et al. "Otorhinolaryngological myiasis: the problem and its presentations in the weak and forgotten." Ghana Med J 2020. [PMID: 33883762]
6. Kuo H et al. "Nasal myiasis in patients with disturbance of consciousness: A case report and literature review." J Central South Univ Med Sci 2021. [PMID: 35232917]
7. Salmanzadeh S et al. "Nasal Myiasis: A Case Report." Iran J Public Health 2018. [PMID: 30320018]
8. Sharma H, Dayal D, Agrawal SP. "Nasal myiasis: review of 10 years experience." J Laryngol Otol 1989; 103:489-491.
9. Tay SY et al. "Treatment of nasal myiasis with ivermectin irrigation." BMJ Case Rep 2018.
10. Shimizu S et al. "Nosocomial Megaselia spiracularis Nasal Myiasis." Intern Med 2026. [PMID: 40803864]
11. Francesconi F, Lupi O. "Myiasis." Clin Microbiol Rev 2012; 25:79-105.

Examiner's tip: For 10 marks, the must-hits are: definition + etiology (species names), predisposing factors (atrophic rhinitis), clinical features (crawling sensation + visible larvae), endoscopic diagnosis, treatment (endoscopic removal + ivermectin), complications (intracranial extension), and prevention. Staging by Sharma is a high-yield addition.

• Teal section banners for all 12 subheadings
• Styled tables (predisposing factors, symptoms, staging, investigations, complications, summary)
• Highlighted citation boxes for textbook quotes
• Gold examiner's tip box at the end
• Full reference list (12 references)
• Clean A4 layout, print-ready